Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Can iron be a risk factor for coronary lesions in Kawasaki disease?

  • Yoon, Kyung Lim (Department of Pediatrics, Kyung Hee University Hospital at Gangdong)
  • Received : 2019.03.25
  • Accepted : 2019.06.07
  • Published : 2019.08.15
Download PDF
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Li X, Chen Y, Tang Y, Ding Y, Xu Q, Sun L, et al. Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases. Eur J Pediatr 2018;177:1279-92. https://doi.org/10.1007/s00431-018-3182-2
  2. Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, et al. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease. Pediatr Rheumatol Online J 2017;15:17. https://doi.org/10.1186/s12969-017-0149-1
  3. Nairz M, Theurl I, Wolf D, Weiss G. Iron deficiency or anemia of inflammation? : Differential diagnosis and mechanisms of anemia of inflammation. Wien Med Wochenschr 2016;166:411-23. https://doi.org/10.1007/s10354-016-0505-7
  4. Fleming RE, Bacon BR. Orchestration of iron homeostasis. N Engl J Med 2005;352:1741-4. https://doi.org/10.1056/NEJMp048363
  5. Kuo HC, Yang YL, Chuang JH, Tiao MM, Yu HR, Huang LT, et al. Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease. J Clin Immunol 2012;32:746-52. https://doi.org/10.1007/s10875-012-9668-1
  6. Huang YH, Kuo HC, Huang FC, Yu HR, Hsieh KS, Yang YL, et al. Hepcidin-induced iron deficiency is related to transient anemia and hypoferremia. Int J Mol Sci 2016;17(5). pii: E715. https://doi.org/ 10.3390/ijms17050715.
  7. Kim SH, Eun LY. Iron deficiency anemia as a predictor of coronary artery abnormalities in Kawasaki disease. Korean J Ped 2019:62:301-6. https://doi.org/10.3345/kjp.2018.06905
  8. Yamamoto N, Sato K, Hoshina T, Kojiro M, Kusuhara K. Utility of ferritin as a predictor of the patients with Kawasaki disease refractory to intravenous immunoglobulin therapy. Mod Rheumatol 2015;25: 898-902. https://doi.org/10.3109/14397595.2015.1038430